Participants will obtain an overall understanding of the principles of non-clinical safety evaluation with an emphasis on the practical application of these principles and the interpretation of non-clinical safety data. Regulatory toxicology in drug development will be emphasised, from both a European and a US perspective.
The course is intended to benefit those from both biotechnology and pharmaceutical companies as well as CROs working with either small or large molecules, along with those from regulatory agencies and academia who are interested in toxicology and its application in the safety assessment of drugs and medical products. Early career scientists seeking a more in-depth knowledge and understanding of the role of toxicology in safety assessment will also benefit. The course is suitable for scientists trained in ancillary disciplines (such as chemistry, biochemistry, molecular biology, medicine, etc.) looking to make a career change to work in drug safety assessment.